Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot Study

Autor: Maria Elena Pugliese, Riccardo Battaglia, Antonio Cerasa, Maria Girolama Raso, Francesco Coschignano, Angela Pagliuso, Roberta Bruschetta, Giovanni Pugliese, Paolo Scola, Paolo Tonin

Publikováno v: Journal of Clinical Medicine, Vol 10, Iss 5830, p 5830 (2021)
Journal of clinical medicine (2021). doi:10.3390/jcm10245830
info:cnr-pdr/source/autori:Maria Elena Pugliese; Riccardo Battaglia; Antonio Cerasa; Maria Girolama Raso; Francesco Coschignano; Angela Pagliuso; Roberta Bruschetta; Giovanni Pugliese; Paolo Scola; Paolo Tonin/titolo:Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot Study/doi:10.3390%2Fjcm10245830/rivista:Journal of clinical medicine/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 10; Issue 24; Pages: 5830

Objective: In the last year, a large amount of research has investigated the anti-spike protein receptor-binding domain (S-RBD) antibody responses in patients at high risk of developing severe acute respiratory syndrome because of COVID-19 infection.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769247cd446dbd5832f22b6457fef6ae
https://doi.org/10.3390/jcm10245830